Trial Profile
The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2014
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 28 Apr 2014 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Nov 2013 New trial record